S
Scinai Immunotherapeutics Ltd. (SCNI)
NCM – Real Time Price. Currency in USD
0.25
-0.00 (-1.57%)
At close: Jun 26, 2026, 4:00 PM EDT
0.25
+0.00 (0.40%)
After-hours: Jun 26, 2026, 6:28 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.25
-0.00 (-1.57%)
At close: Jun 26, 2026, 4:00 PM EDT
0.25
+0.00 (0.40%)
After-hours: Jun 26, 2026, 6:28 PM EDT
No Data
There are no news for this stock.
Total debt $3.5M significantly exceeds cash reserves ($3.1M), raising financial stability concerns
Total current assets $3.6M exceed Total current liabilities $2.7M, highlighting excellent liquidity
Debt-to-equity ratio (0.3) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-22.0x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$1.5M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.35 | 6.05 | 7.0 | |
| Quick ratio | 1.35 | 5.63 | 7.0 | |
| Debt to Equity | 0.30 | 0.30 | 8.0 | |
| Debt to Assets | 0.20 | 1.04 | 8.0 | |
| Interest coverage | -22.03 | -16.91 | 1.0 | |
| Weighted average score | 6.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | 661K | 1M | 1M |
| Gross Profit | -560K | -513K | -2M | -4M | -1M |
| Operating Income | -11M | -10M | -9M | -8M | -5M |
| Net Income | -6M | -6M | 5M | -8M | -3M |
| EBITDA | -10M | -9M | -7M | -6M | -2M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | N/A | 1.0 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | N/A | N/A | 1.0 |
| Next year | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 84.98 | 271.84 | N/A | N/A | 5.5 |
| Y/Y | -16.33 | 330.31 | N/A | -39.29 | 3.3 |
| 3y average | 699.29 | -37.23 | N/A | 5.55 | 4.3 |
| 5y average | 819.17 | -182.74 | N/A | 15.67 | 5.3 |
| Weighted average score | 4.6 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |